Literature DB >> 15031049

Hepatocellular carcinoma.

R S Dawe.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15031049     DOI: 10.1016/S0140-6736(04)15751-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.

Authors:  Yi Zhang; Wen-Jie Song; Fu-Qin Zhang; Wei-Hui Liu; Ke-Feng Dou
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

2.  Endothelial progenitor cells homing to the orthotopic implanted liver tumor of nude mice.

Authors:  Zhi Zhu; Gang Chen; Xingrui Li; Qian Yin; Zhifang Yang; Jilin Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

3.  Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy.

Authors:  Ruey-Shyang Soong; Ming-Chin Yu; Kun-Ming Chan; Hong-Shiue Chou; Ting-Jung Wu; Chen-Fang Lee; Tsung-Han Wu; Wei-Chen Lee
Journal:  World J Surg Oncol       Date:  2011-01-27       Impact factor: 2.754

4.  Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.

Authors:  Wei Gan; Yong Yi; Yipeng Fu; Jinlong Huang; Zhufeng Lu; Chuyu Jing; Jia Fan; Jian Zhou; Shuangjian Qiu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

5.  RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell.

Authors:  Yan Zhao; Wang Jian; Wei Gao; Ya-Xin Zheng; Yong-Kun Wang; Zhu-Qing Zhou; Hui Zhang; Cong-Jun Wang
Journal:  Cancer Cell Int       Date:  2013-03-08       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.